iRhythm Technologies, Inc. — Director's Dealing 2020

Aug 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: iRhythm Technologies, Inc. (IRTC)
CIK: 0001388658
Period of Report: 2020-08-12

Reporting Person: King Kevin M (President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-12	Common Stock	M	57792	$17	Acquired	287562	Direct
2020-08-12	Common Stock	M	1830	$8.18	Acquired	289392	Direct
2020-08-12	Common Stock	S	25694	$178.757	Disposed	263698	Direct
2020-08-12	Common Stock	S	17272	$179.5466	Disposed	246426	Direct
2020-08-12	Common Stock	S	3558	$181.1289	Disposed	242868	Direct
2020-08-12	Common Stock	S	3102	$181.9863	Disposed	239766	Direct
2020-08-12	Common Stock	S	3989	$182.7665	Disposed	235777	Direct
2020-08-12	Common Stock	S	6007	$184.0681	Disposed	229770	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-12	Employee Stock Option (right to buy)	$17.0	M	57792	Disposed	2026-10-19	Common Stock (57792.0)	Direct
2020-08-12	Employee Stock Option (right to buy)	$8.18	M	1830	Disposed	2025-12-15	Common Stock (1830.0)	Direct

Footnotes

F1: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 20, 2019.

F2: Includes 258 shares acquired under the Issuer's employee stock purchase plan on May 29, 2020.

F3: This transaction was executed in multiple trades at prices ranging from $178.25 to $179.24 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F4: This transaction was executed in multiple trades at prices ranging from $179.25 to $180.03 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F5: This transaction was executed in multiple trades at prices ranging from $180.47 to $181.40 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F6: This transaction was executed in multiple trades at prices ranging from $181.56 to $182.24 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F7: This transaction was executed in multiple trades at prices ranging from $182.57 to $182.85 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F8: This transaction was executed in multiple trades at prices ranging from 183.83 to $184.82 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

F9: The option, originally granted for 81,595 shares, of which 57,795 shares have been exercised, vested as to 1/4 of the shares on September 21, 2017 and as to 1/36 of the remaining shares each month thereafter.

F10: All of the shares subject to this option are fully vested and exercisable as of the date hereof.